Get the Stockscreener App
2.31
2.12%
-0.05
Ambev S A Adr stock is traded at $2.31, with a volume of 16.77M.
It is down -2.12% in the last 24 hours and down -0.86% over the past month.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving Interbrew (now AB InBev) a controlling interest of 61.8% as at the end of 2023.
See More
Previous Close:
$2.36
Open:
$2.33
24h Volume:
16.77M
Relative Volume:
0.61
Market Cap:
$36.38B
Revenue:
$16.14B
Net Income/Loss:
$2.89B
P/E Ratio:
12.80
EPS:
0.1804
Net Cash Flow:
$4.06B
1W Performance:
-6.48%
1M Performance:
-0.86%
6M Performance:
-3.75%
1Y Performance:
-11.15%
1-Day Range:
$2.29
$2.345
1-Week Range:
$2.29
$2.46
52-Week Range:
$2.01
$3.00
Ambev S A Adr Stock (ABEV) Company Profile
Name
Ambev S A Adr
Sector
Industry
Phone
-
Address
-
Ambev S A Adr Stock (ABEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-08-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Dec-07-23 | Initiated | Citigroup | Buy |
| Nov-22-23 | Initiated | Jefferies | Hold |
| Jul-10-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-24-23 | Initiated | Bernstein | Outperform |
| Jan-12-23 | Upgrade | UBS | Sell → Buy |
| Jul-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-03-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-06-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Initiated | Goldman | Sell |
| Jun-17-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-20-21 | Downgrade | Itau BBA | Outperform → Market Perform |
| Apr-26-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-03-20 | Upgrade | Citigroup | Neutral → Buy |
| Jul-31-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-24-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-25-20 | Downgrade | HSBC Securities | Hold → Reduce |
| Dec-03-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-27-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-26-19 | Upgrade | JP Morgan | Underweight → Neutral |
| May-21-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Oct-25-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-12-17 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-10-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-03-16 | Resumed | Barclays | Equal Weight |
| Aug-18-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-05-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-01-15 | Upgrade | JP Morgan | Neutral → Overweight |
View All
Ambev S A Adr Stock (ABEV) Latest News
Ambev S.A. ADR (ABEV) is looking forward to a strong quarter - SETE News
What to expect from Ambev S.A. ADR’s (ABEV) current quarter earnings? - US Post News
Post-Trade Analysis: Ambev S.A. ADR (ABEV) Slides -1.66, Closing at 2.37 - The Dwinnex
Understanding the Risks of Investing in Ambev S.A. ADR (ABEV) - Knox Daily
ABEV Stock: Exploring Ambev S.A. ADR’s Growth - The InvestChronicle
The New York Stock Exchange | NYSE - NYSE
A Tale of Resilience: Ambev S.A. ADR Amid Stock Market Turbulence - The InvestChronicle
ABEV’s Q2 earnings estimates: What investors need to know - US Post News
Sea Limited Sponsored ADR (SE) Stock Moves -0.17%: What You Should Know - MSN
Anheuser-Busch InBev S.A. ADR outperforms market despite losses on the day - MSN
Anheuser-Busch InBev SA/NV (BUD) Stock Price, News, Quote & History - Yahoo Finance
Ambev S.A. (ABEV) Stock Price, News, Quote & History - Yahoo Finance
RLX Technology Inc ADR (RLX) Volatility Hits 8.76%: What Good Investors Need To Be Aware Of - Stocks Register
KE Holdings Inc ADR’s (BEKE) Stock Is Harder To Predict Than You Think - Stocks Register
Ambev S.A. ADR (ABEV) Has Recovered 21.48% From Its Low: Is This The Beginning Of A Trend? - Stocks Register
Virgin Galactic Holdings Inc (SPCE) With A Potential Upside Of More Than -696.02% - Stocks Register
Barclays Downgrades Ambev S.A. ADR (ABEV) to an Equal weight from an Overweight - Knox Daily
8X8 Inc. [EGHT] Insider Activity: An Update for Investors - Knox Daily
Honest Company Inc [HNST] Investment Appeal on the Rise - Knox Daily
Analyzing Roblox Corporation (RBLX) After Recent Trading Activity - Knox Daily
Recent Insider Activity Could Benefit Regenxbio Inc (RGNX) - Knox Daily
Barclays slashes price target on Ambev S.A. ADR [ABEV] – find out why. - The DBT News
Are Finance Stocks Lagging Axa (AXAHY) This Year? - Yahoo Finance
Ambev S.A. ADR (ABEV) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
A closer look at ABEV’s price-to-free cash flow ratio - US Post News
Ambev S.A. ADR (ABEV) Stock Behavior Is Not Predictable - Stocks Register
Anheuser-Busch InBev S.A. ADR underperforms Monday when compared to competitors - MarketWatch
ABEV’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Sold by Davidson Kempner Capital Management LP - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Heron Bay Capital Management - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Callan Capital LLC - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Stake Increased by Moors & Cabot Inc. - Defense World
DekaBank Deutsche Girozentrale Makes New $1.08 Million Investment in Anheuser-Busch InBev SA/NV (NYSE:BUD) - MarketBeat
Anheuser-Busch InBev S.A. ADR rises Thursday, still underperforms market - MSN
Capco Asset Management LLC Buys 7,193 Shares of Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
ABEV Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
ABEV’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Up 0.78%: This Is What Analysts Are Now Forecasting - Stocks Register
Nothing is Better Than Ambev S.A. ADR (ABEV) stock at the moment - SETE News
How does ABEV’s price to cash per share ratio compare in the market? - US Post News
The ABEV Stock Puzzle: Unraveling Ambev S.A. ADR’s Fluctuating Performance - The InvestChronicle
Barclays lifts Ambev S.A. ADR [ABEV] price estimate. Who else is bullish? - The DBT News
What to expect from ABEV’s earnings report this quarter? - US Post News
Weekly Upgrades and Downgrades - InvestorPlace
Does Ambev S.A. ADR (NYSE: ABEV) Still Need To Convince Analysts? - Stocks Register
Ambev S.A. ADR [ABEV] fell -18.93% so far this year. What now? - The DBT News
Ambev S.A. ADR (ABEV) Stock: A Year of Market Fluctuations - The InvestChronicle
Get in on Ambev S.A. ADR’s (ABEV) buy-in window today! - SETE News
The 10 Best Companies to Invest in Now - Morningstar
ABEV stock’s current quarter earnings estimates: What analysts predict? - US Post News
A better buy-in window may exist right now for Ambev S.A. ADR (ABEV) - SETE News
Ambev S A Adr Stock (ABEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):